Koyfin Home > Directory > Health Care > Acorda Therapeutics > EV / Sales (ltm)

Acorda Therapeutics EV / Sales (ltm) Chart (ACOR)

Acorda Therapeutics annual/quarterly EV / Sales (ltm) from 2010 to 2020.
  • Acorda Therapeutics EV / Sales (ltm) for the quarter ending September 09, 2020 was 1.33 a -1.16% decrease of -0.02 year over year
  • Acorda Therapeutics EV / Sales (ltm) for the last 12 months ending September 09, 2020 was 1.33 a -1.16% decrease of -0.02 year over year
  • Acorda Therapeutics Annual EV / Sales (ltm) for 2020 was 1.33 a 0.26% increase of 0.00 from 2019
  • Acorda Therapeutics Annual EV / Sales (ltm) for 2020 was 1.32 a -0.51% decrease of -0.01 from 2019
  • Acorda Therapeutics Annual EV / Sales (ltm) for 2020 was 1.33 a -0.91% decrease of -0.01 from 2019
Other Valuation Metrics:
  • Acorda Therapeutics Market Cap for the quarter ending March 03, 2018 was $1,110m a 17.15% increase of 190m year over year
  • Acorda Therapeutics Price / Book for the quarter ending March 03, 2018 was 2.11 a 35.48% increase of 0.75 year over year
  • Acorda Therapeutics Enterprise Value for the quarter ending March 03, 2018 was $1,138m a 2.19% increase of 25m year over year
View Chart On Koyfin

Quarterly ACOR EV / Sales (ltm) Data

09/20201.33
09/20201.32
09/20201.33
09/20201.34
09/20201.33
09/20201.32
09/20201.30
09/20201.30
09/20201.31
09/20201.31

Annual ACOR EV / Sales (ltm) Data

20201.33
20201.32
20201.33
20201.34
20201.33
20201.32
20201.30
20201.30
20201.31
20201.31